Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma
暂无分享,去创建一个
Louise C. Showe | Michael K. Showe | D. Virok | A. Loboda | L. Showe | M. Showe | J. Johnston | A. Rook | Andrey Loboda | Celia Chang | Calen Nichols | M. Wysocka | C. Nichols | Celia Chang | E. Vonderheid | Laszlo Kari | Michael Nebozhyn | Dezso Virok | Wen-Hwai Horng | Alain H. Rook | Eric C. Vonderheid | James Johnston | Maria Wysocka | L. Kari | Wenhwai Horng | M. Nebozhyn
[1] J. Downward,et al. Chemokines Fail to Up-Regulate β1 Integrin-Dependent Adhesion in Human Th2 T Lymphocytes1 , 2000, The Journal of Immunology.
[2] K. Shigesada,et al. Human T cell L-plastin bundles actin filaments in a calcium-dependent manner. , 1992, Journal of biochemistry.
[3] R. Willemze,et al. DISTINCTIVE ADHESION PATHWAYS ARE INVOLVED IN EPITHELIOTROPIC PROCESSES AT DIFFERENT SITES , 1996, The Journal of pathology.
[4] J. Schellens,et al. Ras biochemistry and farnesyl transferase inhibitors: a literature survey , 2001, Anti-cancer drugs.
[5] K. Rottner,et al. Functional design in the actin cytoskeleton. , 1999, Current opinion in cell biology.
[6] A. Rook,et al. The immunopathogenesis of cutaneous T-cell lymphoma. , 1995, Hematology/oncology clinics of North America.
[7] M. Arpin,et al. Functional differences between L- and T-plastin isoforms , 1994, The Journal of cell biology.
[8] R. Flavell,et al. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells. , 1997, Journal of immunology.
[9] S. Lessin,et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. , 1994, The Journal of investigative dermatology.
[10] J. Galon,et al. Stat4 Is Expressed in Activated Peripheral Blood Monocytes, Dendritic Cells, and Macrophages at Sites of Th1-Mediated Inflammation1 , 2000, The Journal of Immunology.
[11] W. Macey,et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. , 1996, Journal of the American Academy of Dermatology.
[12] G. Trinchieri,et al. CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .
[13] T. Lue,et al. Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. , 1999, DNA and cell biology.
[14] A. Ridley. Rho Proteins: Linking Signaling with Membrane Trafficking , 2001, Traffic.
[15] A. Varghese,et al. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. , 1999, Archives of dermatology.
[16] J. Eberwine,et al. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Whittaker,et al. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. , 2003, Blood.
[18] Yuen Ren Chao,et al. Human Behavior and the Principle of Least Effort: An Introduction to Human Ecology , 1950 .
[19] S. Narumiya,et al. Rho effectors and reorganization of actin cytoskeleton , 1997, FEBS letters.
[20] J. Guilhou,et al. Decreased expression of Fas (APO‐1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T‐cell lymphomas , 2000, The British journal of dermatology.
[21] J. Sedat,et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. , 2001, Immunity.
[22] R. Edelson. Cutaneous T Cell Lymphoma , 2001, The Journal of dermatologic surgery and oncology.
[23] Shigemi Kinoshita,et al. Activation of the PKB/AKT pathway by ICAM-2. , 2002, Immunity.
[24] M. Edidin,et al. Selective export of MHC class I molecules from the ER after their dissociation from TAP. , 2000, Immunity.
[25] J. O’Shea,et al. Inducible Expression of Stat4 in Dendritic Cells and Macrophages and Its Critical Role in Innate and Adaptive Immune Responses1 , 2001, The Journal of Immunology.
[26] A. de Matteis,et al. Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] J. Pober,et al. Human Endothelial Cell Presentation of Antigen and the Homing of Memory/Effector T Cells to Skin , 2001, Annals of the New York Academy of Sciences.
[28] R. Tibshirani,et al. Penalized Discriminant Analysis , 1995 .
[29] A. Rook,et al. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. , 1992, The Journal of investigative dermatology.
[30] G. Wood,et al. Cutaneous lymphoid hyperplasias. , 2000, Seminars in cutaneous medicine and surgery.
[31] L. Showe,et al. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. , 1999, Journal of immunology.
[32] G. Trinchieri,et al. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. , 1999, Clinical immunology.
[33] A. Varghese,et al. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. , 1995, Archives of dermatology.
[34] G. Prendergast,et al. Actin' up: RhoB in cancer and apoptosis , 2001, Nature Reviews Cancer.
[35] G. Trinchieri,et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 , 1996, The Journal of experimental medicine.
[36] R. Flavell,et al. Regulation of IL‐4 expression by the transcription factor JunB during T helper cell differentiation , 1999, The EMBO journal.
[37] A. Rao,et al. Molecular aspects of T-cell differentiation. , 2000, British medical bulletin.
[38] S. Sebti,et al. Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues , 2000, Expert opinion on investigational drugs.
[39] P. Allavena,et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. , 2001, The Journal of clinical investigation.
[40] S. Lessin,et al. Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. , 1996, The Journal of investigative dermatology.
[41] T. Luft,et al. IL-1β Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation1 , 2002, The Journal of Immunology.
[42] R. Feinmesser,et al. [Kimura's disease and angiolymphoid hyperplasia with eosinophilia-- on disease with different expressions?]. , 1998, Harefuah.
[43] N. Dang,et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. , 2001, American journal of clinical pathology.
[44] S. Lessin,et al. The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells. , 1993, Archives of dermatology.
[45] K. Bacon,et al. The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia , 2000, Journal of Immunology.
[46] W. Macey,et al. Photopheresis: clinical applications and mechanism of action. , 1999, The journal of investigative dermatology. Symposium proceedings.
[47] K. Tashiro,et al. Versican Interacts with Chemokines and Modulates Cellular Responses* , 2001, The Journal of Biological Chemistry.
[48] R. Flavell,et al. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. , 1997, Journal of immunology.
[49] A. Dorner,et al. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[50] R. Strieter,et al. Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. , 1994, Clinical immunology and immunopathology.
[51] David B. Allison,et al. A mixture model approach for the analysis of microarray gene expression data , 2002 .
[52] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] R. Dummer,et al. Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). , 1996, Blood.
[54] R. Edelson. Cutaneous T cell lymphoma: the helping hand of dendritic cells. , 2001, Annals of the New York Academy of Sciences.